Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse

European Journal of Neuroscience

Volumn 12, Issue 8, 2000, Pages 2892-2900

  Bezard, Erwan ^a   Jaber, Mohamed ^b,d   Gonon, François ^b   Boireau, Alain ^c   Bloch, Bertrand ^b   Gross, Christian E ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c SANOFI   (France)

^d INSERM   (France)

Author keywords

Compensation; Cytochrome oxidase; Dopamine transporter; Immunohistochemistry; Parkinson's disease; Tyrosine hydroxylase; Voltammetry

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C OXIDASE; DOPAMINE;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BASAL GANGLION; DISEASE SEVERITY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOWN REGULATION; ENZYME ACTIVITY; MALE; MOUSE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CARRIER PROTEINS; CELL COUNT; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRIC STIMULATION; ELECTRON TRANSPORT COMPLEX IV; ELECTROPHYSIOLOGY; HOMOVANILLIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED STRAINS; MPTP POISONING; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA; SYNAPTOSOMES; TRITIUM; TYROSINE 3-MONOOXYGENASE;

EID: 0033811169     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00180.x     Document Type: Article

References (55)

1. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats
2. Estimation of nuclear population from microtome sections
3. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat
4. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat
5. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
6. Dopaminergic neurons intrinsic to the primate striatum
7. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms
8. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
9. Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach
10. Experimental models of Parkinson's disease: From the static to the dynamic
11. Long-term induction of tyrosine hydroxylase: Compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain
12. Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence
13. Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry
14. Verteilung von Noradrenalin 7und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems
15. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain
16. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals
17. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo
18. Quantitative histochemistry of cytochrome oxidase in rat brain
19. Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization
20. The MPTP-treated mouse as a model of parkinsonism: How good is it?
21. Some features of the nigrostriatal neurotoxin MPTP in the mouse
22. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat
23. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease
24. A new chronic MPTP model: Validation in monkey and mouse
25. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter
26. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
27. Intricate regulation of tyrosine hydroxylase activity and gene expression
28. Quantitative in situ hybridization using radioactive probes to study gene expression in heterocellular systems
29. Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry
30. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease
31. Midbrain dopaminergic neurons in the mouse: Computer-assisted mapping
32. Regional alterations in neuronal activity in dystonic hamster brain determined by quantitative cytochrome oxidase histochemistry
33. The in vivo microdialysis recovery of dopamine is altered independently of basal level by 6-hydroxydopamine lesions to the nucleus accumbens
34. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: A model for neuron aging
35. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
36. Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain
37. Time course of nigrostriatal degeneration in parkinson's disease
38. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats
39. A mathematical model of pathogenesis in idiopathic parkinsonism
40. A new experimental model of hypokinesia
41. Dopamine efflux from striatal slices after intracembral 6-hydroxydopamine: Evidence for compensatory hyperactivity of residual terminals
42. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage
43. Pharmacology of evoked dopamine release studied in the olfactory tubercle by in vivo electrochemistry
44. Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo
45. Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents
46. Tyrosine hydroxylase-like immunomactive neurons in the striatum of the rat
47. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons
48. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system
49. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and nonhuman primates: A cytochrome oxidase histochemistry study
50. Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake
51. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity
52. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage
53. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications
54. Animal models of parkinsonism using selective neurotoxins: Clinical and basic implications